TNF and rheumatoid arthritis: However, with approximately 50 individuals affected by rheumatoid arthritis per 100,000 inhabitants globally and TNF inhibitors comprising the most frequently prescribed immune modulators, this burden to diligently monitor patients who are either slated to take TNF inhibitors or already taking them extends beyond individuals from high-risk countries (Almutairi et al., 2021).